ADC189 Shows Promise as a Single-Dose Treatment for Influenza

ADC189 shows promise as a single-dose treatment for influenza

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality.

A single shot of a flu drug could outperform vaccines—and protect for an entire season

One injection of a long-lasting drug showed up to 76% efficacy in a large trial

Cidara Therapeutics stock rockets after positive flu prevention trial ...

Cidara Therapeutics Doubles As A Universal Flu Shot Becomes A Closer ...

Cidara stock soars as antiviral drug succeeds in flu study

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu prevention.

Cidara reports outcomes from trial of CD388 for preventing seasonal influenza

Cidara Therapeutics has reported encouraging top-line outcomes from the Phase IIb NAVIGATE trial of CD388.The post Cidara reports outcomes from trial of CD388 for preventing seasonal influenza appeared first on Clinical Trials Arena.